Insider filing
Traded Nov 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MBRX · NASDAQ · Pharmaceutical Preparations
$7.93+1.18 (+17.48%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day
Moleculin Biotech (MBRX) · oqro.io/stocks/MBRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Including 30 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Nov 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Nov 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Nov 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Nov 17 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Nov 16, 2026 · largest single transaction 362
Nov 16, 2026362
DetailsOfficial recordNov 16, 2026
Traded Nov 16, 2026 · largest single transaction 577
Nov 16, 2026577
DetailsOfficial recordNov 16, 2026577
Insider filing
Traded Nov 16 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Nov 16 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Nov 4, 2026 · largest single transaction 17
Nov 4, 202617
DetailsOfficial recordNov 4, 202618
Traded Nov 4, 2026 · largest single transaction 57
Nov 4, 202657
DetailsOfficial recordNov 4, 202657
Traded Nov 4, 2026 · largest single transaction 41
Nov 4, 202641
DetailsOfficial recordNov 4, 202641
Insider filing
Traded Nov 4 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Nov 4 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Nov 4 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Oct 15, 2026 · largest single transaction 260K
Oct 15, 2026260K
DetailsOfficial recordOct 15, 2026260K
Insider filing
Traded Oct 15 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Oct 15, 2026 · largest single transaction 415K
Oct 15, 2026415K
DetailsOfficial recordOct 15, 2026415K
Traded Oct 15, 2026 · largest single transaction 208K
Oct 15, 2026208K
DetailsOfficial recordOct 15, 2026208K
Traded Oct 15, 2026 · largest single transaction 130K
Oct 15, 2026130K
DetailsOfficial recordOct 15, 2026130K
Insider filing
Traded Oct 15 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Oct 15 · filed 2 days later
Routine share withholding; mechanical by default.
Insider buying
Traded Jun 23, 2025 · filed the same day
Since the trade −94.2% · S&P 500 +19.3% · to Nov 19
The CEO of Moleculin Biotech paid $250K out of pocket for Moleculin Biotech shares. 1 other person at Moleculin Biotech bought some too, in the same month. Shares held went up 995% with this purchase.
Insider buying
Traded Jun 23, 2025 · filed the same day
Since the trade −94.2% · S&P 500 +19.3% · to Nov 19
The CFO of Moleculin Biotech paid $100K out of pocket for Moleculin Biotech shares. 1 other person at Moleculin Biotech bought some too, in the same month. Shares held went up 1561% with this purchase.
0 open-market purchases and 0 open-market sales by insiders of MBRX between Feb 17, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 16, 2026. The data provider lists the next release for Mar 16, 2027; that date may change.
PurchaseSale
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 16, 2026 | None | None | None |
| Aug 14, 2026 | None | None | None |
| May 15, 2026 | None | None | None |
| Mar 19, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies